Sitka Biopharma nets $1.9 mln
Vancouver, British Columbia-based Sitka Biopharma, a preclinical biotechnology company, has raised $1.9 million in funding. The investors were Quark Venture Inc. and GF Securities. The capital will be used to complete Sitka's clinical trials for a drug that treats bladder cancer.
25 October 2018•1 min read
